BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng R, Zhuo Z, Luo Y, Sha W, Chen H. Rho GTPase signaling in rheumatic diseases. iScience 2022;25:103620. [PMID: 35005558 DOI: 10.1016/j.isci.2021.103620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Adhikari UK, Khan R, Mikhael M, Balez R, David MA, Mahns D, Hardy J, Tayebi M. Therapeutic anti-amyloid β antibodies cause neuronal disturbances. Alzheimers Dement 2022. [PMID: 36515320 DOI: 10.1002/alz.12833] [Reference Citation Analysis]
2 Papadopoulou D, Roumelioti F, Tzaferis C, Chouvardas P, Pedersen A, Charalampous F, Christodoulou-vafeiadou E, Ntari L, Karagianni N, Denis M, Olsen J, Matralis A, Kollias G. Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis.. [DOI: 10.1101/2022.08.02.500956] [Reference Citation Analysis]
3 Murphy EP, Crean D. NR4A1-3 nuclear receptor activity and immune cell dysregulation in rheumatic diseases. Front Med 2022;9. [DOI: 10.3389/fmed.2022.874182] [Reference Citation Analysis]
4 Sauzeau V, Beignet J, Bailly C. Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder. Biomedicines 2022;10:1357. [PMID: 35740379 DOI: 10.3390/biomedicines10061357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]